MedPath

STUDY OF DEXMEDETOMIDINE VERSUS LIGNOCAINE INFUSION ON EXTUBATION QUALITY

Not Applicable
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2023/05/053286
Lead Sponsor
ESIC MC PGIMSR and Model Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patient willing to give informed consent.

2. Patients age between 18 and 60 years of either gender.

3. American society of anesthesiologists physical status (ASA) grade 1 and grade 2 patients.

4. Patients scheduled for elective laparoscopic cholecystectomy surgeries.

Exclusion Criteria

1. Patient allergy to dexmedetomidine, Lignocaine and other alpha-2 agonists.

2. Patients on pain perception modifying drugs and beta blockers.

3. Patient with impaired mental status, Alcohol or drug abuse.

4. Pregnant patients and patients with autonomic neuropathies.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath